FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for ipratropium bromide submitted by Oceanside Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

SUPPL AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)